真人做爰48姿势视图片|少妇真人直播免费视频|日本真人做爰A片|真人裸体做爰视频|真人与拘做爰视频免费观看|真人与拘做受免费视频一

胃泌素抑制肽(GIP)單克隆抗體

Monoclonal Antibody to Gastric Inhibitory Polypeptide (GIP)

Incretin hormone; Glucose Dependent Insulinotropic Peptide

  • 胃泌素抑制肽(GIP)單克隆抗體 產品包裝(模擬)
  • 胃泌素抑制肽(GIP)單克隆抗體 產品包裝(模擬)
  • Certificate 通過ISO 9001、ISO 13485質量體系認證

特異性

該抗體是針對GIP的小鼠單克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別GIP。

用法

免疫印跡:0.2-2μg/mL;1:500-5000
免疫組織化學:5-20μg/mL;1:50-200
免疫細胞化學:5-20μg/mL;1:50-200
最佳稀釋倍數最終由用戶決定。

儲存

經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。

穩定性

熱穩定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當的條件下存儲,損失率低于5%。

贈品

相關產品

編號 適用物種:Pan-species (General,通用) 應用(僅供研究使用,不用于臨床診斷!)
PAA882Ge01 胃泌素抑制肽(GIP)多克隆抗體 WB; IHC; ICC; IP.
MAA882Ge21 胃泌素抑制肽(GIP)單克隆抗體 WB; IHC; ICC; IP.
MAA882Ge28 胃泌素抑制肽(GIP)單克隆抗體 WB; IHC; ICC; IP.
CEA882Ge 胃泌素抑制肽(GIP)檢測試劑盒(酶聯免疫吸附試驗法) Enzyme-linked immunosorbent assay for Antigen Detection.

參考文獻

雜志 參考文獻
Scientific Reports The?anti-hyperglycemic?efficacy?of a?lipid-lowering?drug?Daming?capsule?and the?underlyingsignaling?mechanisms?in a?rat?model?of?diabetes?mellitus. [pubmed:27721485]
Obesity surgery The Effects of Duodenojejunal Omega Switch in Combination with High-Fat Diet and Control Diet on Incretins, Body Weight, and Glucose Tolerance in Sprague-Dawley Rats. [pubmed:28840471]
Obesity?Surgery? Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague?… [Pubmed:29098544]
BioMed Research International Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity []
Diabetes Research and Clinical Practice Low AS160 and high SGK basal phosphorylation associates with impaired incretin profile and type 2 diabetes in adipose tissue of obese patients [Pubmed: 31734225]
OBESITY SURGERY The Leading Role of Peptide Tyrosine Tyrosine in Glycemic Control After Roux-en-Y Gastric Bypass in Rats [Pubmed: 31701411]
FUTURE SCIENCE Prediction scale of response to liraglutide therapy as the method for increase of treatment efficacy in type 2 diabetes [Pubmed:35251693]
留言咨詢
阜平县| 宝坻区| 青海省| 衡阳市| 望城县| 胶南市| 资讯 | 沈阳市| 彰武县| 双江| 蚌埠市| 封开县| 金平| 昌江| 长春市| 台北县| 中超| 攀枝花市| 营山县| 定结县| 资阳市| 合川市| 郴州市| 前郭尔| 大埔区| 凤台县| 衡水市| 马尔康县| 太康县| 沧州市| 宕昌县| 兴山县| 耒阳市| 洱源县| 宁安市| 定日县| 吉首市| 高陵县| 巫溪县| 龙山县| 贵阳市|